Logo

Nanogen

Apr 18, 2003
Premium

Nanogen last week rolled out kits for the detection of Alzheimer’s disease, Canavan disease, and beta thalassemia. The Alzheimer’s and Canavan products are analyte-specific reagents for creating tests for mutations. All three products are used on NanoChip microarrays.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.